You have 9 free searches left this month | for more free features.

double-dummy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Allergic Rhinitis Trial in São Paulo (Administration of investigation of Eurofarma drug, Administration of Comparator)

Not yet recruiting
  • Allergic Rhinitis
  • Administration of investigation of Eurofarma drug
  • Administration of Comparator
  • São Paulo, Brazil
    Eurofarma Laboratorios S.A
Dec 12, 2022

Urinary Tract Infection, Acute Pyelonephritis Trial (TBP-PI-HBr, Imipenem-cilastatin, Dummy Infusion)

Not yet recruiting
  • Urinary Tract Infection
  • Acute Pyelonephritis
  • (no location specified)
Sep 22, 2023

Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)

Not yet recruiting
  • Essential Hypertension
  • NW Roselle
  • Captopril 25Mg Tab
  • (no location specified)
Nov 15, 2023

Overweight, Obesity Trial in São Paulo (ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg, ADF2

Not yet recruiting
  • Overweight
  • Obesity
  • ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg
  • +3 more
  • São Paulo, SP, Brazil
    HC-FMUSP
Jul 28, 2022

COPD Trial (HRG2005 inhalation, Placebo to match HRG2005 inhalation, Placebo to match Indacaterol Maleate and Glycopyrronium

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • HRG2005 inhalation
  • +3 more
  • (no location specified)
Sep 7, 2023

Diabetes, Type 2 Trial (NW Low-Glu®, Metformin)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • (no location specified)
Nov 20, 2023

Gout, Hyperuricemia, Gout Flare Trial (Tigulixostat, Allopurinol, Placebo)

Not yet recruiting
  • Gout
  • +3 more
  • (no location specified)
Jan 10, 2023

Abuse Potential Trial in Salt Lake City (gabapentin 600 mg, gabapentin 1200 mg, gabapentin 1800 mg)

Completed
  • Abuse Potential
  • gabapentin 600 mg
  • +4 more
  • Salt Lake City, Utah
    Pharmaceutical Research Associates, Inc.
Dec 22, 2022

Helicobacter Pylori Infection Trial in Beijing (Tegoprazan)

Not yet recruiting
  • Helicobacter Pylori Infection
  • Beijing, Beijing, China
    Peking University Third Hospital
Oct 9, 2022

Healthy Trial in Melbourne (PUR3100, Dihydroergotamine (D.H.E 45), Matching Placebo for PUR3100)

Recruiting
  • Healthy
  • Melbourne, Victoria, Australia
    Nucleus Network Melbourne
Jun 23, 2022

Urticaria Trial (Desloratadine, Cetirizine, )

Terminated
  • Urticaria
  • (no location specified)
Feb 7, 2022

Urticaria Trial (desloratadine, , cetirizine)

Completed
  • Urticaria
  • (no location specified)
Feb 7, 2022

Asthma Trial (QVM149, Salmeterol Xinafoate / Fluticasone Propionate, Placebo to QVM149)

Not yet recruiting
  • Asthma
  • (no location specified)
Mar 18, 2023

COVID-19 Trial (Huashi Baidu Granule, Monapiravir)

Not yet recruiting
  • COVID-19
  • (no location specified)
Dec 5, 2022

Pain Trial (FDC of codeine 30 mg/dipyrone 500 mg, Tylex)

Not yet recruiting
  • Pain
  • FDC of codeine 30 mg/dipyrone 500 mg
  • Tylex
  • (no location specified)
Aug 10, 2022

Acute Ischemic Stroke, Large Vessel Occlusion, Reperfusion Trial (Low-dose Y-6 sublingual tablets, High-dose Y-6 sublingual

Not yet recruiting
  • Acute Ischemic Stroke
  • +2 more
  • Low-dose Y-6 sublingual tablets
  • +4 more
  • (no location specified)
Nov 14, 2023

Reflux Esophagitis, Gastroesophageal Reflux, Esophagitis Trial in Shanghai (Anaprazole sodium 40 mg, Anaprazole sodium 60 mg,

Not yet recruiting
  • Reflux Esophagitis
  • +6 more
  • Anaprazole sodium 40 mg
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Changhai Hospital
Nov 1, 2022

Pain Trial in Brooklyn (Ketamine via Intravenous, Ketamine via BAN)

Recruiting
  • Pain
  • Ketamine via Intravenous
  • Ketamine via BAN
  • Brooklyn, New York
    Maimonides Medical Center
Oct 19, 2022

Telogen Effluvium Trial (BL 3000, Reference Pantogar, BL3000 Placebo)

Not yet recruiting
  • Telogen Effluvium
  • BL 3000
  • +3 more
  • (no location specified)
Jul 5, 2022

Primary Dysmenorrhea Trial in São Paulo (CDE100 association, Buscopan® Composto association)

Not yet recruiting
  • Primary Dysmenorrhea
  • CDE100 association
  • Buscopan® Composto association
  • São Paulo, SP, Brazil
    Investigational Site
Jan 16, 2023

Herpetic Neuralgia Trial in Wuhan (HSK16149 20mg BID, HSK16149 40mg BID, Pregabalin 150mg)

Recruiting
  • Herpetic Neuralgia
  • HSK16149 20mg BID
  • +2 more
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Feb 28, 2023

Uncomplicated Urinary Tract Infections Trial in Anniston, La Mesa, Chicago (GSK3882347, Nitrofurantoin, Placebo)

Recruiting
  • Uncomplicated Urinary Tract Infections
  • Anniston, Alabama
  • +4 more
Dec 2, 2022

Urinary Tract Infections Trial (Gepotidacin, Nitrofurantoin, Placebo)

Not yet recruiting
  • Urinary Tract Infections
  • (no location specified)
Dec 9, 2022

Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • (no location specified)
Sep 20, 2023

Androgenetic Alopecia Trial (Finlândia Association + finasteride , Minoxidil + finasteride)

Not yet recruiting
  • Androgenetic Alopecia
  • Finlândia Association + finasteride placebo
  • Minoxidil + finasteride
  • (no location specified)
Aug 3, 2022